Highnoon Laboratories Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	584.23	1,494	212.55	287.4	817.06
Short-Term Investments	400.37	166.93	469.67	-	-
Trading Asset Securities	2,659	3,472	1,699	1,339	2,060
Cash & Short-Term Investments	3,644	5,133	2,381	1,626	2,877
Cash Growth	-29.01%	115.53%	46.43%	-43.47%	47.00%
Accounts Receivable	4,401	2,424	2,167	1,330	694.69
Other Receivables	437.49	349.88	455.85	488.7	52.57
Receivables	4,838	2,773	2,623	1,819	747.25
Inventory	6,220	5,106	5,189	4,393	2,450
Prepaid Expenses	33.54	41.46	33.85	49.95	22.53
Other Current Assets	122.83	124.1	317.78	545.42	354
Total Current Assets	14,858	13,177	10,545	8,434	6,451
Property, Plant & Equipment	4,400	3,891	4,084	2,394	1,823
Goodwill	0.83	0.83	0.83	0.83	0.83
Other Intangible Assets	37.85	46.87	32.29	35.84	21.62
Long-Term Deferred Tax Assets	-	-	-	4.89	37.25
Other Long-Term Assets	85.37	49.82	81.39	87	56.03
Total Assets	19,437	17,231	14,743	10,957	8,390
Accounts Payable	1,974	1,815	909.03	685.29	262.62
Accrued Expenses	801.56	912.21	1,025	792.24	572.89
Short-Term Debt	301.8	784.23	260.37	511.8	46.62
Current Portion of Long-Term Debt	3.9	128.9	66.4	2.57	178.62
Current Portion of Leases	112.76	65.98	273.54	74.08	29.75
Current Income Taxes Payable	876.94	-	-	124.62	296.56
Current Unearned Revenue	237.94	233.6	85.66	74.9	70.07
Other Current Liabilities	595.77	423.62	454.25	306.01	339.28
Total Current Liabilities	4,905	4,364	3,074	2,572	1,796
Long-Term Debt	2.42	318.82	647.72	15.44	-
Long-Term Leases	380.82	70.06	255.02	183.93	119.76
Long-Term Unearned Revenue	-	-	-	5.59	10.24
Pension & Post-Retirement Benefits	-	-	-	525.07	546.65
Long-Term Deferred Tax Liabilities	250.43	279.38	202.06	-	-
Other Long-Term Liabilities	145.25	403.79	528.77	-	-
Total Liabilities	5,684	5,436	4,708	3,302	2,473
Common Stock	529.83	529.83	529.83	418.84	380.76
Retained Earnings	12,182	10,188	8,380	6,826	5,100
Comprehensive Income & Other	1,041	1,078	1,126	410.14	436.25
Total Common Equity	13,753	11,795	10,036	7,655	5,917
Shareholders' Equity	13,753	11,795	10,036	7,655	5,917
Total Liabilities & Equity	19,437	17,231	14,743	10,957	8,390
Total Debt	801.7	1,368	1,503	787.83	374.74
Net Cash (Debt)	2,842	3,765	878.3	838.46	2,502
Net Cash Growth	-24.50%	328.63%	4.75%	-66.49%	76.55%
Net Cash Per Share	53.64	71.05	16.58	15.83	47.22
Filing Date Shares Outstanding	52.98	52.98	52.98	52.98	52.98
Total Common Shares Outstanding	52.98	52.98	52.98	52.98	52.98
Working Capital	9,954	8,813	7,471	5,862	4,655
Book Value Per Share	259.57	222.62	189.41	144.48	111.68
Tangible Book Value	13,714	11,747	10,003	7,618	5,895
Tangible Book Value Per Share	258.84	221.72	188.79	143.79	111.25
Land	1,079	1,079	764.5	338.4	338.4
Buildings	1,513	1,475	1,263	893.19	798.51
Machinery	4,017	3,823	3,218	2,076	2,155
Construction In Progress	278.09	177.08	722.03	442.02	13.71
Leasehold Improvements	95.3	49.4	49.4	49.4	30.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.